5x mes Search Results


n morpholino ethanesulfonic acid mes  (Chem Impex International)
95
Chem Impex International n morpholino ethanesulfonic acid mes
N Morpholino Ethanesulfonic Acid Mes, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/n morpholino ethanesulfonic acid mes/product/Chem Impex International
Average 95 stars, based on 1 article reviews
n morpholino ethanesulfonic acid mes - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
alphalisa buffer  (Revvity)
92
Revvity alphalisa buffer
(A) Comparison of s-WDR1-Ab levels between healthy donors and patients with esophageal, gastric, colorectal, lung, and breast cancers examined using an amplified luminescence proximity homogeneous assay-linked immunosorbent assay <t>(AlphaLISA).</t> The s-WDR1-Ab levels are shown in a scatter dot plot. *** P<0.001; NS, not significant. (B) s-WDR1-Ab and s-CFL1-Ab levels using the ROC curve analysis between the alive and deceased cases in 192 patients with esophageal carcinoma. ROC curves for WDR1-Ab and CFL1-Ab are presented. The area under the ROC curve, 95% confidence interval, cut-off levels, specificity and sensitivity, and P-values are presented in . Closed circles indicate the positions with the highest sum of sensitivity plus specificity, i.e., the Youden index. The ROC curve analysis was used to calculate the P-values. WDR1, WD repeat-containing protein 1; CFL1, cofilin 1; s-WDR1-Ab, serum anti-WDR1 antibody; s-CFL1-Ab, serum anti-CFL1 antibody; ROC, receiver operating characteristic.
Alphalisa Buffer, supplied by Revvity, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/alphalisa buffer/product/Revvity
Average 92 stars, based on 1 article reviews
alphalisa buffer - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier
mes 4.5  (Femtonics inc)
90
Femtonics inc mes 4.5
(A) Comparison of s-WDR1-Ab levels between healthy donors and patients with esophageal, gastric, colorectal, lung, and breast cancers examined using an amplified luminescence proximity homogeneous assay-linked immunosorbent assay <t>(AlphaLISA).</t> The s-WDR1-Ab levels are shown in a scatter dot plot. *** P<0.001; NS, not significant. (B) s-WDR1-Ab and s-CFL1-Ab levels using the ROC curve analysis between the alive and deceased cases in 192 patients with esophageal carcinoma. ROC curves for WDR1-Ab and CFL1-Ab are presented. The area under the ROC curve, 95% confidence interval, cut-off levels, specificity and sensitivity, and P-values are presented in . Closed circles indicate the positions with the highest sum of sensitivity plus specificity, i.e., the Youden index. The ROC curve analysis was used to calculate the P-values. WDR1, WD repeat-containing protein 1; CFL1, cofilin 1; s-WDR1-Ab, serum anti-WDR1 antibody; s-CFL1-Ab, serum anti-CFL1 antibody; ROC, receiver operating characteristic.
Mes 4.5, supplied by Femtonics inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mes 4.5/product/Femtonics inc
Average 90 stars, based on 1 article reviews
mes 4.5 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


(A) Comparison of s-WDR1-Ab levels between healthy donors and patients with esophageal, gastric, colorectal, lung, and breast cancers examined using an amplified luminescence proximity homogeneous assay-linked immunosorbent assay (AlphaLISA). The s-WDR1-Ab levels are shown in a scatter dot plot. *** P<0.001; NS, not significant. (B) s-WDR1-Ab and s-CFL1-Ab levels using the ROC curve analysis between the alive and deceased cases in 192 patients with esophageal carcinoma. ROC curves for WDR1-Ab and CFL1-Ab are presented. The area under the ROC curve, 95% confidence interval, cut-off levels, specificity and sensitivity, and P-values are presented in . Closed circles indicate the positions with the highest sum of sensitivity plus specificity, i.e., the Youden index. The ROC curve analysis was used to calculate the P-values. WDR1, WD repeat-containing protein 1; CFL1, cofilin 1; s-WDR1-Ab, serum anti-WDR1 antibody; s-CFL1-Ab, serum anti-CFL1 antibody; ROC, receiver operating characteristic.

Journal: Medicine International

Article Title: The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma

doi: 10.3892/mi.2023.71

Figure Lengend Snippet: (A) Comparison of s-WDR1-Ab levels between healthy donors and patients with esophageal, gastric, colorectal, lung, and breast cancers examined using an amplified luminescence proximity homogeneous assay-linked immunosorbent assay (AlphaLISA). The s-WDR1-Ab levels are shown in a scatter dot plot. *** P<0.001; NS, not significant. (B) s-WDR1-Ab and s-CFL1-Ab levels using the ROC curve analysis between the alive and deceased cases in 192 patients with esophageal carcinoma. ROC curves for WDR1-Ab and CFL1-Ab are presented. The area under the ROC curve, 95% confidence interval, cut-off levels, specificity and sensitivity, and P-values are presented in . Closed circles indicate the positions with the highest sum of sensitivity plus specificity, i.e., the Youden index. The ROC curve analysis was used to calculate the P-values. WDR1, WD repeat-containing protein 1; CFL1, cofilin 1; s-WDR1-Ab, serum anti-WDR1 antibody; s-CFL1-Ab, serum anti-CFL1 antibody; ROC, receiver operating characteristic.

Article Snippet: AlphaLISA was conducted using 384-well microtiter plates (white opaque OptiPlate™, PerkinElmer, Inc.) containing 2.5 µl 1/100-diluted sera and 2.5 µl GST, GST-WDR1, or GST-CFL1 (10 µg/ml) in AlphaLISA buffer [25 mM HEPES (pH 7.4), 0.1% casein, 0.5% Triton X-100, 1 mg/ml dextran-500 and 0.05% Proclin-300] following the manufacturer's instructions (PerkinElmer, Inc.) and as previously described ( ).

Techniques: Comparison, Amplification